WRBY Warby Parker Inc.

Q3 2025 10-Q
Filed: Nov 6, 2025Period ending Sep 30, 2025
Health Care
Ophthalmic GoodsSEC EDGAR

Warby Parker Inc. (WRBY) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • New trade tariff risk from recent U.S. tariff increases on imports from China, Italy, Vietnam, Japan raising product costs
  • Most material update: heightened tariffs causing cost escalation uncertainty and potential margin compression or price hikes
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$222M

Net Income

$6M

Gross Margin

54.1%

Operating Margin

1.6%

Net Margin

2.6%

ROE

1.6%

Total Assets

$707M

Source: XBRL data from Warby Parker Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Warby Parker Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.